Instruction Pages The information set out below provides a checklist of information that needs to be included in the model Clinical Investigation Agreement (mCIA) in preparation for execution by the Parties. It is the Sponsor’s responsibility to...Investigation Agreement • September 27th, 2023
Add, remove and / or update recitals as applicable to the Clinical Investigation (as a preamble to the Agreement, such changes do not constitute modification to the template Agreement). Recital D should be completed where a corporate Affiliate of the Sponsor is formally empowered by the Sponsor to sign the Agreement on behalf of the Sponsor thereby binding the Sponsor as Party to the Agreement (and should be removed where this is not the case). Recital E should be retained if the Trial Site is in Northern Ireland and otherwise deleted.
CLINICAL INVESTIGATION AGREEMENT FOR MEDICAL TECHNOLOGY INDUSTRY SPONSORED RESEARCH IN NHS HOSPITALS [Name – Clinical Investigation] This agreement dated …………………………………… is between […. insert name….] NHS [FOUNDATION] TRUST, of [.…insert address….]...Investigation Agreement • August 20th, 2020 • England and Wales
WHEREAS the Sponsor is a medical technology company involved in the research, development, manufacture and sale of medical devices for use in humans
ContractInvestigation Agreement • September 18th, 2022
NO PROFIT CLINICAL INVESTIGATION AGREEMENT FOR THE DRUGS “_________________________________" BETWEEN the Azienda Ospedaliero-Universitaria Ospedali Riuniti “Umberto I° - G.M. Lancisi - G. Salesi”, headquartered in Ancona, 71 Conca Street, tax code and VAT no.01464630423, through its Legal Representative Dr Michele Caporossi, in the capacity of Director General, , who has granted Dr. Cinzia Cocco, (position of signatory prot.739934 on July 6th 2020) with the powers to enter into this Agreement (hereinafter the “Entity”) AND (a) __________ (insert name of Sponsor), headquartered in _____________, tax code and VAT no. …............, as Legal Representative ______, as _______________ (hereinafter the “Sponsor”) Or (b) (If mandate given to the CRO) ________(insert the name of the Contract Research Organization - CRO), headquartered in ________, tax code and VAT no.________, through its Legal Representative, _______________ as ____________, (hereinafter the "CRO"), acting in the name and on
THIS INVESTIGATION AGREEMENT is made on 2015Investigation Agreement • February 12th, 2015 • Florida
aCLINICAL INVESTIGATION AGREEMENT FOR THE DRUGS BETWEENInvestigation Agreement • January 24th, 2022
IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA, headquartered in Via Albertoni 15, 40138 Bologna, tax code: 92038610371, VAT registration number: 02553300373, legally represented by the Director of the U.O.C. Research and Innovation, Dott.ssa Luigia Scudeller, delegated to sign this deed under the resolution no. 28 of 02/02/2018, as confirmed by resolution no. 255 of 31/10/201 (hereinafter the “Entity")
IS BETWEEN ROYAL BROMPTON & HAREFIELD NHS TRUST OF SYDNEY STREET, LONDON SW3 6NP UK (HEREINAFTER KNOWN AS THE "TRUST") AND HEARTWARE, INC. 3351 EXECUTIVE WAY MIRAMAR, FL 33023-3935 U.S.A. (HEREINAFTER KNOWN AS THE "SPONSOR") NOWInvestigation Agreement • April 30th, 2007 • HeartWare LTD
CLINICAL INVESTIGATION AGREEMENT FOR MEDICAL TECHNOLOGY INDUSTRY SPONSORED RESEARCH IN NHS HOSPITALSInvestigation Agreement • May 1st, 2014 • England and Wales
WHEREAS the Sponsor is a medical technology company involved in the research, development, manufacture and sale of medical devices for use in humans
